Protein degradation, cell therapy, synergistic combinations and changes in personalized cancer therapies will drive the next generation of therapeutics, but not necessarily in the ways people might expect. Personalized cancer therapy, for example, seems to be losing ground to other therapies simply because of logistics and finances. “Speed of manufacturing and the cost of getting […]

COVID-19-Related Celltrion Group announced Phase I results from its antibody cocktail of Regkirona and CT-P63. One Phase I study tested CT-P63 in 24 healthy participants in Poland. The trial hit the primary objective of safety and tolerability. It also demonstrated strong neutralizing activity against the Omicron variant. CT-P63 is a monoclonal antibody that targets the SARS-CoV-2 spike […]

Within hours of the news that the J.P. Morgan (JPM) Healthcare Conference would be held virtually in 2022, hotel prices in San Francisco plummeted from thousands of dollars per night to a few hundred for the same rooms. Some 24 hours later, Biotech Showcase – a premier partnering event for small biotech companies – also announced its […]